Evidence of Epstein–Barr Virus in Female Breast Cancer
Abstract
No Abstract
1. Jazayeri SB, Saadat S, Ramezani R, Kaviani A (2015). Incidence of primary breast cancer in Iran: Ten-year national cancer registry data report. Cancer Epidemiol, 39(4):519-27.
2. Oskouee MA, Shahmahmoodi S, Jalilvand S, et al (2014). No evidence of mammary tumor virus env gene-like sequences among Iranian women with breast cancer. Intervirology, 57(6):353-6.
3. Mozaffari HR, Ramezani M, Janbakhsh A, Sadeghi M (2017). Malignant salivary gland tumors and Epstein-Barr virus (EBV) infection: a systematic review and meta-analysis. Asian Pac J Cancer Prev, 18(5): 1201–1206.
4. Kadivar M, Monabati A, Joulaee A, Hosseini N (2011). Epstein-Barr virus and breast cancer: lack of evidence for an association in Iranian women. Pathol Oncol Res, 17(3):489-92.
5. Lao TD, Nguyen DH, Nguyen TM, Le TAH (2017). Molecular Screening for Epstein-Barr virus (EBV): Detection of Genomic EBNA-1, EBNA-2, LMP-1, LMP-2Among Vietnamese Patients with Nasopharyngeal Brush Samples. Asian Pac J Cancer Prev, 18(6):1675-1679.
6. Morales-Sanchez A, Fuentes-Panana E (2014). Human viruses and cancer. Viruses, 6(10): 4047–4079.
7. Labrecque LG, Barnes DM, Fentiman IS, Griffin BE (1995). Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res, 55:39-45.
8. Arbach H, Viglasky V, Lefeu F, et al (2006). Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol). J Virol, 80(2):845-53.
9. Joshi D, Quadri M, Gangane N, Joshi R, Gangane N (2009). Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women. PloS One, 4(12):e8180.
10. Fadavi P, Rostamian M, Arashkia A, et al (2013). Epstein-barr virus may not be associated with breast cancer in Iranian patients. Oncol Discover, 1(3):1-3.
2. Oskouee MA, Shahmahmoodi S, Jalilvand S, et al (2014). No evidence of mammary tumor virus env gene-like sequences among Iranian women with breast cancer. Intervirology, 57(6):353-6.
3. Mozaffari HR, Ramezani M, Janbakhsh A, Sadeghi M (2017). Malignant salivary gland tumors and Epstein-Barr virus (EBV) infection: a systematic review and meta-analysis. Asian Pac J Cancer Prev, 18(5): 1201–1206.
4. Kadivar M, Monabati A, Joulaee A, Hosseini N (2011). Epstein-Barr virus and breast cancer: lack of evidence for an association in Iranian women. Pathol Oncol Res, 17(3):489-92.
5. Lao TD, Nguyen DH, Nguyen TM, Le TAH (2017). Molecular Screening for Epstein-Barr virus (EBV): Detection of Genomic EBNA-1, EBNA-2, LMP-1, LMP-2Among Vietnamese Patients with Nasopharyngeal Brush Samples. Asian Pac J Cancer Prev, 18(6):1675-1679.
6. Morales-Sanchez A, Fuentes-Panana E (2014). Human viruses and cancer. Viruses, 6(10): 4047–4079.
7. Labrecque LG, Barnes DM, Fentiman IS, Griffin BE (1995). Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res, 55:39-45.
8. Arbach H, Viglasky V, Lefeu F, et al (2006). Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol). J Virol, 80(2):845-53.
9. Joshi D, Quadri M, Gangane N, Joshi R, Gangane N (2009). Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women. PloS One, 4(12):e8180.
10. Fadavi P, Rostamian M, Arashkia A, et al (2013). Epstein-barr virus may not be associated with breast cancer in Iranian patients. Oncol Discover, 1(3):1-3.
Files | ||
Issue | Vol 50 No 2 (2021) | |
Section | Letter to the Editor | |
DOI | https://doi.org/10.18502/ijph.v50i2.5368 | |
PMCID | PMC7956096 | |
PMID | 33748013 | |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
ALINEZHAD F, AHANGAR OSKOUEE M, BANNAZADEH BAGHI H, TAMIRI OSKOUEE S, ESMAEILI H-A. Evidence of Epstein–Barr Virus in Female Breast Cancer. Iran J Public Health. 2021;50(2):425-427.